NLG(14)444. DATE OF MEETING 28 October Trust Board of Directors Public REPORT FOR. Infection and Prevention Control Team REPORT FROM
|
|
- Scarlett Gibson
- 5 years ago
- Views:
Transcription
1 NLG(14)444 DATE OF MEETING 28 October 2014 REPORT FOR Trust Board of Directors Public REPORT FROM Infection and Prevention Control Team CONTACT OFFICER Neil Gammon Non-Executive Director/Dr Mark Withers Medical Director SUBJECT Infection and Prevention Control Committee minutes September 2014 BACKGROUND DOCUMENT (IF ANY) NLG(14)400 IPCC Highlight report submitted to September Trust Board REPORT PREVIOUSLY CONSIDERED BY & DATE(S) Ratified by the Infection and Prevention Control Committee EXECUTIVE COMMENT (INCLUDING KEY ISSUES OF NOTE OR, WHERE RELEVANT, CONCERN AND / OR NED CHALLENGE THAT THE BOARD NEED TO BE MADE AWARE OF) HAVE THE STAFF SIDE BEEN CONSULTED ON THE PROPOSALS? HAVE THE RELEVANT SERVICE USERS/CARERS BEEN CONSULTED ON THE PROPOSALS? ARE THERE ANY FINANCIAL CONSEQUENCES ARISING FROM THE RECOMMENDATIONS? IF YES, HAVE THESE BEEN AGREED WITH THE RELEVANT BUDGET HOLDER AND DIRECTOR OF FINANCE, AND HAVE ANY FUNDING ISSUES BEEN RESOLVED? ARE THERE ANY LEGAL IMPLICATIONS ARISING FROM THIS PAPER THAT THE BOARD NEED TO BE MADE AWARE OF? WHERE RELEVANT, HAS PROPER CONSIDERATION BEEN GIVEN TO THE NHS CONSTITUTION IN ANY DECISIONS OR ACTIONS PROPOSED? WHERE RELEVANT, HAS PROPER CONSIDERATION BEEN GIVEN TO SUSTAINABILITY IMPLICATIONS (QUALITY & FINANCIAL) & CLIMATE CHANGE? THE PROPOSAL OR ARRANGEMENTS OUTLINED IN THIS PAPER SUPPORT THE ACHIEVEMENT OF THE TRUST OBJECTIVE(S) AND COMPLIANCE WITH THE REGULATORY STANDARDS LISTED Ensuring effective monitoring of Infection prevention and control ACTION REQUIRED BY THE BOARD To note the contents of the minutes
2 INFECTION PREVENTION & CONTROL COMMITTEE Minutes of the Infection Prevention & Control Committee held on 25 th September 2014 at pm in the Modular Meeting Room SGH with vtc to the Small Meeting Room DPoW PRESENT: Mr Neil Gammon Andy Karvot Debbie O Toole Dr Karen Dunderdale Dr Mark Withers Dr Peter Cowling Dr Tony Vicca Greta Johnson Kathryn Helley Linda Taylor Paul Kirton-Watson Ruth Kent Victoria Grainger Viv Duncanson Laura Owen Non-Executive Director (Chair) Consultant Antimicrobial Pharmacist Head of Occupational Health & Wellbeing Chief Nurse Medical Director Consultant Microbiologist Consultant Microbiologist Community Services Infection Control Nurse Deputy Director of Performance & Asst Trust Secretary Health Protection Nurse Specialist, Public Health England Associate Chief Nurse Head of CT/MRI Senior Healthcare Scientist Assistant Senior Nurse, Infection Control/Assistant DIPC PA to Medical Director (minute taker) 1. Apologies for Absence Apologies were received from the following; Dr Jim Whittingham Karen Jackson Wendy Booth Chairman Chief Executive Director of Clinical and Quality Assurance 2. Minutes of the previous meeting The Committee ratified the minutes of 21 st July Neil Gammon wanted to address the various agenda setting concerns raised prior to this meeting; currently Dr Mark Withers, Viv Duncanson and Neil Gammon meet to set the agenda, 2 weeks prior to the meeting. Action: Future agenda call s will be distributed from Laura Owen prior to the agenda setting meetings. The agenda call will include a deadline: items will not be accepted after the deadline. All papers to be submitted to Laura with completed IPCC front sheets which must include meaningful comments. 3. Matters Arising 3.1) Sign off July 2014 minutes & Quoracy Neil Gammon asked whether the Committee agreed that the correct action was taken at the previous meeting; the Committee was not quorate, but decided for the meeting to still go ahead with a view to seeking formal approval for any actions agreed from the now quorate Committee.
3 Agreed: The Committee agreed the appropriate action was taken and approved the actions of the previous meeting. 3.2) Update on the adherence to Antimicrobial Policy (Minute 3.2 & 3.5 refers) Andy Karvot referred to the document distributed prior to the meeting. This paper showed a number of examples where Trust policy is not being complied with. Dr Withers queried what is currently in place. Dr Cowling explained that traditionally on a regular basis, published guidance from professional/specialty societies is taken into account and Trust policy is updated where necessary, invariably in line with national policy. Further discussion ensued, with some anecdotal examples of unauthorised non-adherence to policy cited. It was agreed that Dr Withers would work with Dr Cowling to ensure that either Trust antimicrobial prescribing policy was being adhered to or that appropriate derogations were sought and approved in accordance with an agreed procedure. Action: Dr Withers to provide an update for November IPCC. Andy Karvot raised an additional concern regarding the Nationally mandated Antimicrobial Steering Group which continues to be poorly attended, as this is a Sub-Committee of the board, Andy asked whether this should be brought to the attention of the Trust Board. Action: Dr Cowling, Dr Vicca and Andy Karvot to meet to discuss outside of this meeting. Neil Gammon to add to the highlight report for the Trust Board. 3.3) Protocol for new starters (Minute 3.4 refers) The Committee previously discussed the protocol for new starters particularly with regards to chickenpox vaccines. It has been agreed that we will offer vaccines for chickenpox to all new starters who have not previously been vaccinated. Occupational Health are currently waiting for the Patient Group Directive (PGD) to be authorised through pharmacy before this can be implemented. Action: Karen Dunderdale agreed to hasten the PGD with Pharmacy as they can often take a considerable amount of time to be processed. 3.4) Review of the Do not escalate form (Minute 5.1 refers) Viv Duncanson explained that the proposal to introduce a Do Not Escalate form resulted from some MRSA bacteremia RCA investigations. Dr Withers suggested that it may be appropriate to include this form within the overall Do Not Resuscitate policy. This suggestion would need to go through the Trust Management Board and End of Life (EoL) group for approval. Action: Dr Withers agreed to steer this proposed change through the EoL Care group prior to taking it to Trust Management Board. 3.5) Glove Risk Assessment (Minute refers) The IPCT has produced posters etc. in readiness for the launch of The gloves are off campaign. 3.6) Updated IPCC ToRs The Committee agreed that a sentence should be added under Quorum of the ToR to say that if the meeting is not quorate the meeting can still go ahead but that all decisions would need to be approved subsequently by a quorate IPCC. Action: Laura Owen to update the ToR. Page 2 of 7
4 3.7) Risk Register outstanding items Viv Duncanson met with Jill Mill and updated all the outstanding items highlighted at the previous meeting. 3.8) Intravascular access Dr Cowling explained that this is an additional matter arising which was highlighted in the IPCC annual report. Within the report it is discussed losing a key member of staff from intravascular access, which is going to affect the ability to insert PICC lines which will cause a significant risk to patients and the Trust for MRSA bacteremia. Dr Dunderdale agreed it is a significant risk to the organisation that we are seeing the invasive devices team ebb away, the existing team looks in addition to placing PICCs also oversee the intravenous follow up care. Viv Duncanson advised that a replacement nurse has been appointed but does not have experience in insertion of PICC lines, it generally takes 6 months to become competent in the insertion of PICC lines. Dr Vicca suggested staff grade anesthetists could be considered as an option. Action: Dr Withers, Dr Dunderdale and Viv Duncanson to meet to discuss further, with an update to the November IPCC. 4. Items for Discussion 4.1) MRSA Screening Viv Duncanson presented a DoH paper containing modified admission MRSA screening guidance. The DoH and the Antimicrobial Resistance and Healthcare Associated Infection Advisory Committee (ARHAI) have asked us to review our policy. The advice is to discontinue screening all patients on admission and to only screen patients admitted to high risk units and all persons previously identified as being at risk for MRSA. Viv Duncanson presented an updated MRSA policy to reflect this advice. Action: The Committee agreed for NLAG policy to be distributed for any final comments with a 2 week deadline. The team will then launch the policy after the deadline for comments. 4.2) IPC training stats Viv Duncanson referred the Committee to the IPC training statistics distributed. This will become a standing agenda item. 4.3) High risk infection patients (VHF) Viv Duncanson explained that this item was originally added to the agenda regarding the potential purchase of a pod to be used in the case of presentation of a patient with high infection risk however this has been overtaken by a recent potential case review at SGH. Viv referred the Committee to the Ebola GAP analysis / action plan and letter distributed with the meeting papers. Most of the issues highlighted in the action plan will be discussed in the Ebola debrief meeting which is being arranged following the suspected Ebola case with Dr Withers taking the lead. NB The case was confirmed as malaria, but the presentation and subsequent actions has allowed the Trust to test preparedness for Ebola. Action: Feedback from Dr Withers from the Ebola de-brief meeting to be added to the November IPCC agenda for discussion. Page 3 of 7
5 4.4) 6 monthly progress reports for; Infection Control Annual Progress Viv Duncanson referred the Committee to the annual progress report distributed with the meeting papers; the Trust is currently waiting for a revised version of the hygiene code before review of this item. The Trust have achieved the targets for quarter 1 for the C.difficile CQUIN. HCAI development plan Viv Duncanson advised that we are on track with the majority of the actions. She reported that she has developed a tool to investigate Hospital Acquired Pneumonia and is awaiting appropriate clinician lead here through the M&M group. Hospital at home is currently rated amber and the Committee agreed to transfer this action to the COO s area. Action: Viv Duncanson to Karen Griffiths to advise that the action concerning the hospital at home is being removed and give a hand over. The Continence group is making good head way. The WHO guidance, use of soap and alcohol rub is complete and the action can be made green. The SharePoint action is also complete and can now be made green. Action: Laura Owen to add HCAI development plan for January as an agenda item with regards to input from committee members for the 2014/15 plan. 4.5) Annual International Infection Control week October 2014 Viv Duncanson explained that during Infection Control Week, commencing 14 October 2014, the IPC team plan to use concentrate on cleaning of equipment by use of ATP swabs making the invisible visible / how clean is your kit and we are not too posh to wash are strap lines that will be used.. Various other activities planned to raise awareness including competitions. 4.6) Removal of Penicillin Allergy Labelling Andy Karvot referred the Committee to the document distributed with the meeting papers. Andy explained that it was agreed at the July IPCC meeting for this to be discussed at the November meeting however Andy would like comments from the group whilst it is in draft so that it can be discussed at the November meeting. He has concerns as to the risks such a policy may pose to the Trust and these need to be properly explored by expert members of the IPCC. This will also need to go to the Medical Records Committee (MRC) as well as Safer Medications and Medicines Management Team. 4.7) NLaG Antimicrobials Action Plan Andy Karvot advised that this is the action plan from the Antimicrobial Steering Group which has already been distributed to the Committee. Andy has received comments from Dr Withers. Action: Andy will review and update the NLaG Antimicrobials Action Plan based on comments received and report back to IPCC in November ) Meropenem Snapshot Audit Andy Karvot explained that it was noted at the Trust Board that this Trust is the second highest user of carbapenems within the Yorkshire and Humber Region, when usage is adjusted for size. However, the results of the audit show we are using carbopenems particularly meropenems accordingly and appropriately. Page 4 of 7
6 Action: Neil Gammon to add to the highlight report for the Trust Board. 4.9) AMU/CDU Rapid Cycle Antibiotics Prescribing Audit Cycle Andy Karvot explained in their present format, these audits this did not appear to have the desired effect on compliance with national and Trust standards for antimicrobials prescribing. Professor Sewell had suggested superimposing doctors work rotas on the run-charts for the audit results to try and identify those doctors who are not prescribing to standards. A trial of the modified process is to begin in October, Andy has discussed with Mr Ashaolu who felt that 100% compliance will not be achieved with Trust treatment sheets in their current format and that they require a dedicated antimicrobials prescribing section, which Andy will explore. Action: Andy Karvot to discuss with Mike Urwin, Chief Pharmacist and the safer medication Committee to make the changes to prescription documents. 4.10) Monthly SSTF Antibiotic Prescribing Audits Andy Karvot explained that the July data shows that at SGH, compliance with antibiotic prescribing standards continues to improve, but at DPoW standards have dropped. Andy asked the Committee to note that there appear to be differing standards between the sites. Dr Dunderdale and Dr Vicca asked how there can be such a high percentage of unidentified prescribers. Andy explained that this was due to illegible signatures without names underneath in capitals and the recording of on-call bleep numbers passed from person-to-person was also causing an issue. These issues will be rectified once electronic prescribing is in place. 4.11) Antimicrobials Prescribing Strategy Discussed within agenda item Standing Items 5.1) MRSA Action Plan Action: Viv Duncanson to update Do Not Escalate to say that it has gone to the EoL Group 5.2) C Difficile Action Plan Viv Duncanson advised we have 2 C.diff DIPC review meetings outstanding which are currently being arranged by Laura Owen. The Trust have had 9 hospital acquired C.diff cases, of the 7 DIPC reviews that have been held, 6 were not preventable, and only 1 case was preventable. 5.3) CPE Action Plan Viv Duncanson advised that all actions are now complete and implemented. Numerous training sessions were being carried out. Action: To remove as a standing item. Dr Dunderdale and Neil Gammon to take the CPE plan to the Trust Board to advise of sign off. 5.4) Infection control audit challenge 5.4.1) FLO tool (front line ownership) Viv Duncanson explained that this is a summary of each ward with months and overall scores. The audit looks at 10 sections of infection prevention practice. The new FLO tool was launched in Page 5 of 7
7 April 14 and gives more meaningful scores as well as a more thorough audit. From September onwards nil returns will not be tolerated and will be escalated. The audit is a quite extensive selfaudit but for those areas that are scoring consistently high, it has been agreed they can go to quarterly self-auditing, subject to approval from Viv Duncanson and the relevant Head of Nursing ) Hand hygiene spreadsheet Viv reminded the Committee that any failures need escalating by the matrons to Laura Owen in order that the zero tolerance policy (letter from either the Chief Nurse or Medical Director and 1:1 training with an IPCN can kick in. It was believed that many failures are not currently being escalated to the Medical Director ) 5 moments hand hygiene audit Viv advised that there have been a couple of nil returns which already get reviewed at NMAF. Viv informed that Laura Owen has only received 1 hand hygiene escalation from Paediatrics. Action: Dr Dunderdale to pick up with HoN to escalate any hand hygiene failures to Laura Owen Action: Training stats to be added to future agendas under ) Update Site Specific Groups 6. Policies/Items for ratification 6.1) Derogation of Cath Lab at SGH Dr Vicca explained that this is regarding a sink in the Cath Lab at SGH. He went on to outline his concerns. These were agreed by the Committee who asked that the derogation be reworded to reflect the position. Action: Viv Duncanson to discuss with Heidi Metcalf and re-circulate to the Committee for any final comments and ratification. 7. Policies/items for Ratification 7.1) Tuberculosis Policy Policy still be reviewed. 7.2) SOPs from ITU at SGH Document not ready for approval 7.3) MRSA Policy Already discussed and agreed 8. Trust Quality Development plan IPCC oversight actions Kathryn Helley referred the Committee to the Trust Quality Development Plan which was distributed with the meeting papers. This has subsumed the Keogh plan. She explained that the plan highlights things we are not doing, however this is now a fairly old paper, an updated version will be going to the Trust Board on Tuesday. The plan is mapped to relevant Sub-Committees and at this point in time there are no actions that sit under the remit of the IPCC. Page 6 of 7
8 Action: Kathryn Helley to provide a copy of the updated paper in readiness for the November IPCC. 9. IPCC Annual self-assessment Greta Johnson updated the IPCC Annual self-assessment whilst at the last meeting, however as the meeting was not quorate it was agreed to bring the updated self-assessment back to this meeting for final sign-off by the Committee. Action: Laura Owen to update the IPCC self-assessment, with the action agreed at today s meeting to now go out with an agenda call for additional items prior to the agenda setting meeting. Action: Any further comments or actions required to forward to Laura Owen for formal sign off at the November meeting. 10. Highlight Report for the Trust Board Neil Gammon to forward the highlight report to Laura Owen for the Trust Board 11. Review of Action Log The Committee noted several updates to the action log were required. Action: Laura Owen to make the necessary amendments and circulate the amended action log accordingly. 12. Items for Information 12.1 ICC Group Minutes DPOW 12.2 ICC Group Minutes SGH 12.3 DPOW C.diff Action Group minutes 12.4 SGH C.diff Action Group minutes 12.5 SGH and DPOW C diff Action Group Action Plans 12.6 Antimicrobial Steering Group Minutes 13. Any Other Business None raised 14. Date & Time of Next Meeting: Date: 17 th November 2014 Time: hrs Venue: DPoW, West Arch Boardroom vtc to SGH Modular Building Page 7 of 7
NLG(13)250. DATE 30 July Trust Board of Directors Part A. Dr Liz Scott, Medical Director REPORT FROM
NLG(13)250 DATE 30 July 2013 REPORT FOR Trust Board of Directors Part A REPORT FROM Dr Liz Scott, Medical Director CONTACT OFFICER Dr Liz Scott, Medical Director SUBJECT Infection Control Committee Minutes
More informationNLG(13)430. DATE 26 November Trust Board of Directors Part A REPORT FOR. Infection Prevention & Control Committee REPORT FROM
NLG(13)430 DATE 26 November 2013 REPORT FOR Trust Board of Directors Part A REPORT FROM Infection Prevention & Control Committee CONTACT OFFICER Professor Carrock Sewell SUBJECT Minutes of the Committee
More informationSHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST EXECUTIVE SUMMARY: BOARD OF DIRECTORS 22 FEBRUARY 2012
SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST EXECUTIVE SUMMARY: BOARD OF DIRECTORS C 22 FEBRUARY 2012 Subject: Supporting : Author: Status (see footnote): Update on the Clostridium difficile (C.diff)
More informationThe safety of every patient we care for is our number one priority
HUMBER NHS FOUNDATION TRUST INFECTION PREVENTION AND CONTROL STRATEGY 2015-2017 1. Introduction Healthcare associated infections (HCAI) continue to be a major cause of patient harm and although nationally
More informationCLOSTRIDIUM DIFFICILE ACTION PLAN
CLOSTRIDIUM DIFFICILE ACTION PLAN Action plan to address the rise in cases of Clostridium difficile (C.diff) at Sheffield Teaching Hospitals NHS Foundation Trust ACTION KEY MILESTONES PERSON RESPONSIBLE
More informationAppendix 1: C.diff elements with the Trust s HCAI recovery Plan and Risk to Delivery
Appendix 1: C.diff elements with the Trust s HCAI recovery Plan and Risk to Delivery Issue Action Risk to Year-end trajectory for C difficile infections is 29 cases. Week commencing 09.12.13 - Performance
More informationTHE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST HEALTHCARE ASSOCIATED INFECTIONS (HCAI)
THE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST HEALTHCARE ASSOCIATED INFECTIONS (HCAI) Agenda item A4(i) EXECUTIVE SUMMARY The paper highlights the increasingly challenging HCAI targets for the
More informationNLG(15)397. Trust Board of Directors Part A. Tara Filby, Acting Chief Nurse N/A N/A
NLG(15)397 DATE OF MEETING 29 th September 2015 REPORT FOR Trust Board of Directors Part A REPORT FROM Tara Filby, Acting Chief Nurse CONTACT OFFICER Tara Filby, Acting Chief Nurse SUBJECT QPEC minutes
More informationQuality, Safety & Experience (QSE) Committee. Minutes of the Meeting Held on Wednesday 29 th March 2017 in the Boardroom, Carlton Court, St Asaph
1 Minutes QSE Public 29.3.17 V1.0 Present: Quality, Safety & Experience (QSE) Committee Minutes of the Meeting Held on Wednesday 29 th March 2017 in the Boardroom, Carlton Court, St Asaph Mrs Margaret
More informationQuality and Safety Committee Terms of Reference
Approved May 2016 Quality and Safety Committee Terms of Reference 1. Constitution The Quality and Safety Committee is established as a sub-committee of The Hillingdon Hospitals NHS Foundation Trust (THH)
More informationInfection Prevention and Control Strategy (NHSCT/11/379)
Infection Prevention and Control Strategy (NHSCT/11/379) September 2010 September 2010 Contents Page No. 1. Foreword 1 2. Introduction 2-3 3. Key Principles 4-5 4. Objectives 6-13 5. Organisational Arrangements
More informationWest Hertfordshire Hospitals NHS Trust Reducing Clostridium difficile infection Action Plan [Updated 19/3/13] Item 37/13
Introduction purpose: West Hertfordshire Hospitals NHS Trust Reducing Clostridium difficile infection Action Plan 2012-2013 [Updated 19/3/13] Item 37/13 This action plan has been developed by West Hertfordshire
More informationWRIGHTINGTON, WIGAN AND LEIGH HEALTH SERVICES NHS TRUST DIRECTOR OF INFECTION PREVENTION AND CONTROL ANNUAL REPORT
WRIGHTINGTON, WIGAN AND LEIGH HEALTH SERVICES NHS TRUST DIRECTOR OF INFECTION PREVENTION AND CONTROL ANNUAL REPORT 2006-2007 Author(s) Gill Harris, Director of Infection Prevention and Control EXECUTIVE
More informationNLG(13)277. DATE 27 August Trust Board of Directors Part A REPORT FOR
NLG(13)277 DATE 27 August 2013 REPORT FOR Trust Board of Directors Part A REPORT FROM Jackson, Chief Executive and Wendy Booth, Director of Clinical and Quality Assurance & Trust Secretary CONTACT OFFICER
More informationCoG (04/17) Item 19. Council of Governors. Item for Information. C difficile Action Plan. To note the report. DATE 11 April 2017 REPORT FOR SUBJECT
CoG (04/17) Item 19 DATE 11 April 2017 REPORT FOR Council of Governors SUBJECT Item for Information TITLE C difficile Action Plan BACKGROUND DOCUMENT (IF ANY) EXECUTIVE COMMENT (INCLUDING KEY ISSUES OF
More informationWOLVERHAMPTON CLINICAL COMMISSIONING GROUP QUALITY & SAFETY COMMITTEE
Wolverhampton Clinical Commissioning Group WOLVERHAMPTON CLINICAL COMMISSIONING GROUP QUALITY & SAFETY COMMITTEE Minutes of the Quality and Safety Committee Meeting held on Tuesday 12 th May 2015 Commencing
More informationRevised East Kent Hospitals University NHS Foundation Trust C. difficile Recovery / Action Plan April 2014
Background Revised East Kent Hospitals University NHS Foundation Trust C. difficile Recovery / Action Plan April 2014 The C.difficile objective for EKHUFT in 2013 2014 was 29 cases and in April 2013, the
More informationReview of Terms of Reference of Quality Assurance Committee
Review of Terms of Reference of Quality Assurance Committee Governing Body meeting 3 May 2018 H Author(s) Sponsor Director Purpose of Paper Sue Laing, Corporate Services Risk and Governance Manager Mandy
More informationInfection Prevention and Control. Quarterly Report
Infection Prevention and Control Quarterly Report 1 st July 2009 30 th September 2009 Dr Nick Harper Director of Infection Prevention and Control Mrs Johanne Lickiss Nurse Consultant Infection Prevention
More informationNorth East Ambulance Service NHS Trust Infection Prevention and Control Annual Work Plan April 2009 March 2010 October review (2)
North East Ambulance Service NHS Trust Infection Prevention and Control Annual Work Plan April 2009 March 2010 October review (2) No. Objective Actions Lead Date of 1 Leadership throughout Accountability
More informationOutbreak Management Policy
Policy No: IC24 Version: 5.0 Name of Policy: Outbreak Management Policy Effective From: 13/09/2012 Date Ratified 27/07/2012 Ratified Infection Prevention & Control Committee Review Date 01/07/2014 Sponsor
More information(Committee Chair) Chair) Interim Board Secretary (MHSA/16/25 onwards) Head of CAMHS and Childrens Learning Disability (MHSA/16/24 only)
POWYS TEACHING HEALTH BOARD MENTAL HEALTH SERVICES ASSURANCE COMMITTEE CONFIRMED MINUTES OF THE MEETING HELD ON THURSDAY 03 MARCH 2016, AT 10.00AM, GROUND CONFERENCE ROOM, NEUADD BRYCHEINIOG, BRECON Present:
More informationREPORT SUMMARY SHEET
Quality care for you, with you REPORT SUMMARY SHEET Meeting: Date: Title: Lead Director: Corporate Objective: Purpose: High level context: Trust Board 29 th September 2016 Infection Prevention and Control
More informationTRUST BOARD. Date of Meeting: 05/10/2010
TRUST BOARD Date of Meeting: 05//20 Enclosure: 7 Agenda Item No: 8.3 Title of Report: Interim Report for Infection Prevention and Control 20-2011 Aims: To inform the Board of the work of the Trust in controlling
More informationSample CHO Primary Care Division Quality and Safety Committee. Terms of Reference
DRAFT TITLE: Sample CHO Primary Care Division Quality and Safety Committee Terms of Reference AUTHOR: [insert details] APPROVED BY: [insert details] REFERENCE NO: [insert details] REVISION NO: [insert
More informationPOLICY FOR TAKING BLOOD CULTURES
Sponsor: Reviewer(s): Dr Roberta Parnaby (Consultant Microbiologist) Dr Alicja Baczynska (F2 Microbiology) Dr Chris Gordon (Medical Director) Dr Roberta Parnaby Dr Matthew Dryden (Consultant Microbiologists)
More informationConnolly Hospital Infection Prevention and Control Quality Improvement Plan 14 th March 2013
Connolly Hospital Infection Prevention and Control Quality Improvement Plan 14 th March 2013 1. Summary The Infection Prevention and Control Quality Improvement Plan clearly defines the priorities for
More informationINFECTION CONTROL SURVEILLANCE POLICY
INFECTION CONTROL SURVEILLANCE POLICY Version: 3 Ratified by: Date ratified: July 2016 Title of originator/author: Title of responsible committee/group: Senior Managers Operational Group Head of Infection
More informationMINUTES. Name of meeting. Quality and Clinical Governance Committee. Date and time Tuesday 2 May :30-17:00. Venue. Board Room, Dominion House
MINUTES Name of meeting Quality and Clinical Governance Committee Date and time Tuesday 2 May 2017 14:30-17:00 Venue Board Room, Dominion House Name Title Chair Dr Sue Tresman (ST) Lay Vice Chair (Lay
More informationPrevention and control of healthcare-associated infections
Prevention and control of healthcare-associated infections Quality improvement guide Issued: November 2011 NICE public health guidance 36 guidance.nice.org.uk/ph36 NHS Evidence has accredited the process
More informationCarbapenemase Producing Enterobacteriaceae (CPE) Prevention and Management Toolkit for Inpatient Areas
Carbapenemase Producing Enterobacteriaceae (CPE) Prevention and Management Toolkit for Inpatient Areas This toolkit includes examples advice leaflets and forms which may be helpful for use by teams or
More informationabc INFECTION CONTROL STRATEGY
abc INFECTION CONTROL STRATEGY 1. INTRODUCTION East and North Hertfordshire NHS Trust (ENHT) considers the reduction of Healthcare Associated infections (HCAI) a key component of patient safety systems
More informationProgress Report on C.Diff Action Plan
NHS GREATER GLASGOW AND CLYDE NHS Board Meeting 16 December 2008 Paper No. 08/55 Board Medical Director Progress Report on C.Diff Action Plan Recommendation The NHS Board is asked to receive this further
More information[Insert organisation logo]
cleanyourhands campaign Solihull Care Trust Why the campaign? In the 21 st century infections continue to be acquired by patients HCAIs cause the deaths of at least 5000 patients every year and cost the
More informationCOMMUNITY AND OLDER PEOPLE S MENTAL HEALTH SERVICE FRAMEWORK FOR:
MINDING THE GAP COMMUNITY AND OLDER PEOPLE S MENTAL HEALTH SERVICE FRAMEWORK FOR: GOVERNANCE ASSURANCE AND PERFORMANCE. 1. INTRODUCTION AND CONTEXT Providing, delivering and developing the highest standards
More informationNHS BOLTON CLINICAL COMMISSIONING GROUP Public Board Meeting AGENDA ITEM NO: 10. Date of Meeting: 31 st August 2018 TITLE OF REPORT:
NHS BOLTON CLINICAL COMMISSIONING GROUP Public Board Meeting AGENDA ITEM NO: 10 Date of Meeting: 31 st August 2018 TITLE OF REPORT: AUTHOR: PRESENTED BY: PURPOSE OF PAPER: (Linking to Strategic Objectives)
More informationInfection Prevention and Control Annual Report Produced by: The Director of Infection Prevention and Control
Infection Prevention and Control Annual Report 2009 Produced by: The Director of Infection Prevention and Control Reviewing the period: January 2009 - December 2009 Approved by Infection Control Committee:
More informationClinical Advisory Forum DRAFT Terms of Reference
Clinical Advisory Forum DRAFT Terms of Reference 1. Constitution 1.1. The Trust Executive Committee (TEC) hereby resolves to establish a Forum to be known as the Clinical Advisory Forum (the Forum). The
More informationRevised Terms of Reference Trust Management Committee
Revised Terms of Reference Trust Management Committee Safe & Effective Kind & Caring Exceeding Expectation Agenda Item No: 11.5 Meeting Date: 26 March 2018 Title: Revised Terms of Reference for Trust Management
More informationMinutes 18 July 3.00pm 4.30pm Surrey Heath House, Knoll Road, Camberley, Surrey GU15 3HD Michele Harrison, Quality Manager
Quality and Clinical Governance Committee Date Chair Minutes 18 July @ 3.00pm 4.30pm Surrey Heath House, Knoll Road, Camberley, Surrey GU15 3HD Michele Harrison, Quality Manager Members Present Gareth
More informationPGDs are permitted for use only by registered health professionals (see enclosed link for full list
NHS England North - Yorkshire and the Humber Region Protocol for the Development, Authorisation and Use of Patient Group Directions for the National Immunisation Programmes 1. Introduction The preferred
More informationQuality Committee Terms of Reference
Quality Committee Terms of Reference 1. Authority 1.1. The Quality Committee (the Committee) is constituted as a standing committee of the Trust Board. The Committee is a Non-Executive Committee and has
More informationJob Title 22 February 2013
Surveillance of Infection Policy HH(1)/IC/613/13 Previous document(s) being replaced Location Policy Policy Name RHCH CP021 Surveillance Policy BNHH IC/289/09 Surveillance of Infection Protocol Document
More informationHow Digital Systems Can Impact on Antimicrobial Stewardship (AMS) Stephen Hughes (Antimicrobial Pharmacist) Chelsea & Westminster Hospital
How Digital Systems Can Impact on Antimicrobial Stewardship (AMS) Stephen Hughes (Antimicrobial Pharmacist) Chelsea & Westminster Hospital Importance of AMS Antimicrobial Resistance: Any selective pressure
More informationCOMPLETION DATE 2.1 Governance Improve medical attendance at IPPC meeting records Clinical Directors Q
University Hospital Waterford (UHW) Quality improvement Plan - HIQA PCHAI Unannounced Monitoring Inspection on 5.9.2017 (Report Published 4 th December 2017) QIP dated 31 st Recommendations Section 2 2.1
More informationArrangements. Version 10
UNIQUE IDENTIFIER NO: C-64-2014 Nurse Section A - Arrangements Version 10 Important: This document can only be considered valid when viewed on the Trust s Intranet. If this document has been printed or
More informationInfection Prevention and Control Policy
Infection Prevention and Control Policy March 2012 Ref: PCD053 (v5) Status: Infection Prevention and Control Policy Policy Reference Number IC017 Status Version 5 Implementation Date September 2007 Current/Last
More informationInfection Prevention. & Control. Report
Infection Prevention & Control Report April 2012 March 2013 Author Joanne Raper, Infection Prevention & Control Nurse Manager Page 1 of 10 1.0 Purpose of the Paper The purpose of this report is to provide
More informationBOARD OF DIRECTORS. Minutes of the Meeting of 29 March 2018 Lecture Theatre 2, Education Centre QEMC
BOARD OF DIRECTORS Minutes of the Meeting of 29 March 2018 Lecture Theatre 2, Education Centre QEMC Present: In Attendance: Observers: Rt Hon Jacqui Smith, Chair Dame Julie Moore, Chief Executive Officer
More informationHand Hygiene Policy. Documentation Control
Documentation Control Reference CL/CGP/039 Approving Body Trust Board Date Approved 3 Implementation date 3 Supersedes NUH Version 2 (May 2009) Consultation undertaken Infection Prevention and Control
More informationCLINICAL GOVERNANCE AND QUALITY COMMITTEE. Final - Terms of Reference - Final
CLINICAL GOVERNANCE AND QUALITY COMMITTEE Final - Terms of Reference - Final CONSTITUTION 1. The Board of Directors approved the establishment of the Clinical Governance and Quality Committee (known as
More informationRoot Cause Analysis Investigation Report. Clostridium Difficile Ian Monro Ward. The Royal National Orthopaedic Hospital
Root Cause Analysis Investigation Report Clostridium Difficile Ian Monro Ward The Royal National Orthopaedic Hospital CONTENTS Incident description and consequences Pre-investigation risk assessment Background
More informationClinical Bleep Policy Version 4.0
Policy Statement: This Policy defines the required standards for Trust Staff in their use of the Trust s Bleep system to ensure patient safety and wellbeing is maximised. Key Points: This Policy relates
More informationClostridium difficile Infection (CDI) Trigger Tool
Hospital ward/clinical Area Date Trigger Tool Commenced Date Trigger Tool Closed Person closing the CDI Trigger Health Protection Scotland V2.0 November 2011 A CDI Trigger is the point at which the Infection
More informationPublic health guideline Published: 11 November 2011 nice.org.uk/guidance/ph36
Healthcare-associated infections: prevention ention and control Public health guideline Published: 11 November 2011 nice.org.uk/guidance/ph36 NICE 2017. All rights reserved. Subject to Notice of rights
More informationChecklists for Preventing and Controlling
Checklists for Preventing and Controlling Clostridium difficile Infection (CDI) This document has been developed to specifically assist senior management and all ward staff to take appropriate actions,
More informationCentral Alerting System (CAS) Policy
Document Title Reference Number Lead Officer Author(s) (name and designation) Ratified By Central Alerting System (CAS) Policy NTW(O)17 Gary O Hare Executive Director of Nursing and Operations Tony Gray
More informationOpen and Honest Care in your Local Hospital
Open and Honest Care in your Local Hospital The Open and Honest Care: Driving Improvement Programme aims to support organisations to become more transparent and consistent in publishing safety, experience
More informationJOB DESCRIPTION. SENIOR PHARMACY ASSISTANT TECHNICAL OFFICER Aseptic Services
JOB DESCRIPTION JOB DETAILS Job Title: SENIOR PHARMACY ASSISTANT TECHNICAL OFFICER Aseptic Services Band: Band 3 Department / Ward: Pharmacy Department Division: Clinical Support Your normal place of work
More informationINFECTION PREVENTION & CONTROL. ANNUAL REPORT Northern Devon Healthcare NHS Trust
INFECTION PREVENTION & CONTROL ANNUAL REPORT 2013-14 Northern Devon Healthcare NHS Trust incorporating community services in Exeter, East and Mid Devon 1 Kevin Marsh David Richards Joint Directors of Infection
More informationThe prevention, management and control of Healthcare Associated Infections (HCAI) in hospitals (ROCR-LITE/08/014/FT6)
NATIONAL AUDIT OFFICE STUDY The prevention, management and control of Healthcare Associated Infections (HCAI) in hospitals (ROCR-LITE/08/014/FT6) National Audit Office study The prevention, management
More informationDate ratified November Review Date November This Policy supersedes the following document which must now be destroyed:
Document Title Reference Number Lead Officer Author(s) (name and designation) Ratified by Cleaning Policy NTW(O)71 James Duncan Deputy Chief Executive / Executive Director of Finance Steve Blackburn Deputy
More informationWarrington CCG Operational Safeguarding Children Health Forum. Terms of Reference
Warrington CCG Operational Safeguarding Children Health Forum 1 Introduction Terms of Reference 1.1 The Operational Safeguarding Children Health Forum (the Health Forum) is established within the Safety
More informationInfection Prevention & Control Annual Report 2011/2012
Infection Prevention & Control Annual Report 2011/2012 Board of Directors Approval date: 1 November 2012 Infection Prevention & Control Committee Submission date: 1 August 2012 Position at 31 March 2012
More informationNHS BOLTON CLINICAL COMMISSIONING GROUP Public Board Meeting AGENDA ITEM NO: 14. Date of Meeting: 29 th June 2018 TITLE OF REPORT:
NHS BOLTON CLINICAL COMMISSIONING GROUP Public Board Meeting AGENDA ITEM NO: 14 Date of Meeting: 29 th June 2018 TITLE OF REPORT: AUTHOR: PRESENTED BY: PURPOSE OF PAPER: (Linking to Strategic Objectives)
More informationClostridium difficile Infection (CDI) Trigger Tool
Hospital ward/clinical Area Date Trigger Tool Commenced Date Trigger Tool Closed Person closing the CDI Trigger Health Protection Scotland March 2014 Version 3.0 A CDI trigger is the number of new CDI
More informationWorkforce and Organisational Development Committee. Minutes of the meeting held on in the Board Room, Ysbyty Gwynedd and via videoconference
Workforce and Organisational Development Committee Minutes of the meeting held on 13.3.14 in the Board Room, Ysbyty Gwynedd and via videoconference Present: Dr P Higson Ms J Dean Dr C Tillson Mr K McDonogh
More informationThis paper provides detail of actions to reduce the incidence of Clostridium difficile at Airedale NHS Foundation Trust (ANHST).
Airedale NHS Foundation Trust Board of Directors: 27 February 2013 Title: Update on Actions to Reduce the Incidence of Clostridium difficile at Airedale NHS Foundation Trust Author: Allison Charlesworth,
More informationInfection Prevention and Control: Audit Policy
Infection Prevention and Control: Audit Policy Document Status Version: 2.0 Approved DOCUMENT CHANGE HISTORY Initiated by Date Author Code of Practice September 2010 Dee May (Infection Control Specialist)
More informationHEI self-assessment. Completing the self-assessment - Guidance to NHS boards
HEI self-assessment Completing the self-assessment - Guidance to NHS boards INTRODUCTION This document should be read in conjunction Healthcare Improvement Scotland healthcare associated infection (HAI)
More information(Committee Chair) Chair) Asst. Lead Director for Children & Strategic Lead for Mental Health. Head of Estates and Property (MHSA/16/01-08 only)
POWYS TEACHING HEALTH BOARD MENTAL HEALTH SERVICES ASSURANCE COMMITTEE CONFIRMED MINUTES OF THE MEETING HELD ON THURSDAY 07 JANUARY 2016, AT 09.30AM, HAFREN TRAINING ROOM, HAFREN WARD, BRONLLYS HOSPITAL
More informationJob Description and Person Specification
Job Description and Person Specification Chief Nursing Officer / Director of Infection Prevention and Control RESPONSIBLE TO: ACCOUNTABLE TO: LIAISES WITH: Chief Executive Chief Executive Executive and
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Clinical Assurance Toolkit (CAT) Strategy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Clinical Assurance Toolkit (CAT) Strategy Effective: January 2014 Review: January 2015 1. Introduction The Trust s Nursing and Midwifery Strategy,
More informationGovernance and Quality Committee Review. Wendy Pugh Director of Operations and Nursing. Innovation Tom Jinks - Governance Manager.
Board meeting date: 29 th May 2013 Agenda Item number:10.1 Enclosure:5 Title and Quality Committee Review Accountable Director: Author (name & title): Wendy Pugh Director of Operations and Nursing Rosie
More informationAnnual Report Infection Prevention and Control. RDaSH. Helen Dabbs Deputy Chief Executive/Director of Nursing & Partnerships
RDaSH Infection Prevention and Control Annual Report Helen Dabbs Deputy Chief Executive/Director of Nursing & Partnerships Dr Deborah Wildgoose Deputy Director of Nursing and Standards Rachel Millard Head
More informationMinutes of the Equality Steering Group held on Wednesday, 18 February 2015 at 10 am in the Boardroom, the Cottage
Minutes of the Equality Steering Group held on Wednesday, 18 February 2015 at 10 am in the Boardroom, the Cottage Present: Pamela Montgomery, Non-Executive Director (Chair) Alison Irwin, Head of Equality
More informationNLG(14)403. DATE OF MEETING 30 th September Trust Board of Directors Public REPORT FOR. Jug Johal, Director of Facilities REPORT FROM
NLG(14)403 DATE OF MEETING 30 th September 2014 REPORT FOR Trust Board of Directors Public REPORT FROM Jug Johal, Director of Facilities CONTACT OFFICER Keith Fowler, Hotel Services General Manager SUBJECT
More informationItem E1 - Bart s Health Quality Indicators
Item E1 - Bart s Health Quality Indicators 1.0 Purpose 1.1 The purpose of this report is to provide the CCG Board with an update on quality matters across pertaining to our main local Provider organisations.
More informationMethods: Commissioning through Evaluation
Methods: Commissioning through Evaluation NHS England INFORMATION READER BOX Directorate Medical Operations and Information Specialised Commissioning Nursing Trans. & Corp. Ops. Commissioning Strategy
More informationCommissioning for Quality and Innovation (CQUIN) Guidance for 2016/17 Published March 2016
Commissioning for Quality and Innovation (CQUIN) Guidance for 2016/17 Published March 2016 Commissioning for Quality and Innovation (CQUIN) Introduction1 The CQUIN scheme is intended to deliver clinical
More informationNHS Clinical Governance Annual Report 2010/2011
NHS Board Meeting 22 June 2011 Paper 3 NHS Board Meeting Wednesday 22 June 2011 Subject: Purpose: Recommendation: NHS Clinical Governance Annual Report 2010/2011 To provide a report containing the key
More informationDirector of Infection Prevention and Control Annual Report 01 April March 2013
Director of Infection Prevention and Control Annual Report 01 April 2012 31 March 2013 Agenda Item: Reference: Meeting Name: Board Meeting Meeting Date: 3 rd June 2013 Lead Director: Lisa Cooper Job Title:
More informationNational Waiting Times Centre Board. Clinical Governance Committee
Board Strategy National Waiting Times Centre Board Name Q-Pulse No Summary Associated documents Target audience Board-Strategy-3 Outlines the Board s approach to delivery of safe and effective care through
More informationVeraz Ltd. Veramedico Infection Preventing & Care Quality Technology
Veraz Ltd Veramedico Infection Preventing & Care Quality Technology Veraz Ltd Is an SME based in Lancaster and employs 15 mainly technical staff Has been developing touch and other innovative technology
More informationQuality Assurance Committee (QAC)
Quality Assurance Committee (QAC) Minutes of the meeting of the Quality Assurance Committee of the Sheffield Health and Social Care NHS Foundation Trust, held on Monday 25 TH April 2016 at 1pm in Rivelin
More informationTerms of Reference Quality Governance Assurance Committee 26 March 2018
Terms of Reference Quality Governance Assurance Committee 26 March 2018 Safe & Effective Kind & Caring Exceeding Expectation Agenda Item No: 11.3 Meeting Date: 26 th March 2018 Trust Board Report Title:
More informationInternal Audit. Health and Safety Governance. November Report Assessment
November 2015 Report Assessment G G G A G This report has been prepared solely for internal use as part of NHS Lothian s internal audit service. No part of this report should be made available, quoted
More informationNHS BOLTON CLINICAL COMMISSIONING GROUP Public Board Meeting AGENDA ITEM NO: 12. Date of Meeting: 23 rd March 2018 TITLE OF REPORT:
NHS BOLTON CLINICAL COMMISSIONING GROUP Public Board Meeting AGENDA ITEM NO: 12 Date of Meeting: 23 rd March 2018 TITLE OF REPORT: AUTHOR: PRESENTED BY: PURPOSE OF PAPER: (Linking to Strategic Objectives)
More informationInspecting Informing Improving. Hygiene code inspection report: West Hertfordshire Hospitals NHS Trust
Inspecting Informing Improving Hygiene code inspection report: West Hertfordshire Hospitals NHS Trust December 2008 Outcome of inspection for: Hospital(s) visited: West Hertfordshire Hospitals NHS Trust
More informationIn Attendance: Arlene Sheppard (AMS) Note Taker WNCCG Sarah Haverson (SHv) Commissioning Support Officer WNCCG
Agenda Item: 17.62 DRAFT Minutes of West Norfolk Primary Care Commissioning Committee Part One (Quorate) Held on 26th May 2017 2pm Education Room, Town Hall, Saturday Market Place, Kings Lynn PE30 5DQ
More informationQUALITY COMMITTEE. Terms of Reference
QUALITY COMMITTEE Terms of Reference CONSTITUTION 1. The Board of Directors approved the establishment of the Quality Committee (known as the Committee in these terms of reference) for the purpose of:
More informationIsolation Care of Patients in Isolation due to Infection or Disease
Infection Prevention and Control Assurance - Standard Operating Procedure 6 (IPC SOP 6) Isolation Care of Patients in Isolation due to Infection or Disease Why we have a procedure? The spread of infection
More informationLearning from Deaths Policy A Framework for Identifying, Reporting, Investigating and Learning from Deaths in Care.
Learning from Deaths Policy A Framework for Identifying, Reporting, Investigating and Learning from Deaths in Care. Associated Policies Being Open and Duty of Candour policy CG10 Clinical incident / near-miss
More informationStandard Operating Procedure Discharge/Transfer of Patients from St John s Hospice In-Patient Unit
Standard Operating Procedure Discharge/Transfer of Patients from St John s Hospice In-Patient Unit DOCUMENT CONTROL: Version: 1.1 Ratified by: Quality Assurance Sub Committee Date ratified: 2 February
More informationDraft Minutes. Agenda Item: 16
Meeting of Bristol Clinical Commissioning Group Quality and Governance Committee Held on 17th December 2013 At 9:00am in Clinical Commissioning Group Meeting Room Agenda Item: 16 Draft Minutes Present:
More informationREPORT SUMMARY SHEET
Quality care for you, with you REPORT SUMMARY SHEET Meeting: Date: Title: Lead Director: Corporate Objective: Purpose: High level context: Trust Board 27 th October 2016 Infection Prevention and Control
More informationPolicy for the Control and Management of patients Colonised or Infected with Vancomycin resistant enterococci (VRE)
Policy for the Control and Management of patients Colonised or Infected with Vancomycin resistant enterococci (VRE) Author: Responsible Lead Executive Director: Endorsing Body: Governance or Assurance
More informationOpen and Honest Care in your Local Hospital
Open and Honest Care in your Local Hospital The Open and Honest Care: Driving Improvement programme aims to support organisations to become more transparent and consistent in publishing safety, experience
More informationHepatitis B Immunisation procedure SOP
Hepatitis B Immunisation Procedure SOP Standard Operating Procedure (SOP) Ref No: 1992 Version: 3 Prepared by: Karen Bennett Presented to: Care and Clinical Policies Sub Group Ratified by: Care and Clinical
More informationApologies Lay Member Financial Management & Audit
Primary Care Commissioning Committee Unratified Minutes of the Public Meeting held on Thursday 2 August 2018, 09:30 10:45 Committee Room, Gedling Civic Centre, Arnot Hill Park Members Mike Wilkins (MW)
More information